Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,476,669

« Back to Dashboard

Summary for Patent: 5,476,669

Title: Method for treatment of gastro intestinal disorders
Abstract:A method is disclosed for preventing the recurrence of duodenal ulcer associated with Campylobacter pylori (Helicobacter pylori) infection in a patient suffering from duodenal ulcer disease associated with Campylobacter pylori infection by administering a pharmaceutically acceptable bismuth compound, a first antibiotic selected from the group consisting of tetracycline and penicillins, and a second antibiotic which is metronidazole.
Inventor(s): Borody; Thomas J. (Five Dock, AU)
Assignee: Examed Australia Pty. Ltd. (New South Wales, AU) Ostapat Pty. Limited (New South Wales, AU) Gastro Services Pty. Limited (New South Wales, AU) Capability Services Pty. Limited (New South Wales, AU)
Application Number:07/937,421
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 5,476,669

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPI4838Oct 12, 1987
AustraliaPI5985Dec 18, 1987
AustraliaPI7513Mar 30, 1988

International Patent Family for Patent: 5,476,669

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada1330759► Subscribe
Germany3887353► Subscribe
European Patent Office0439453► Subscribe
Australia2540588► Subscribe
Australia623868► Subscribe
Austria100324► Subscribe
JapanH03503404► Subscribe
Japan2733849► Subscribe
New Zealand226437► Subscribe
World Intellectual Property Organization (WIPO)8903219► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Harvard Business School
Farmers Insurance
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: